Oxtellar XR (oxcarbazepine) Extended-release Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   December 2015 WARNINGS AND PRECAUTIONS Association with HLA-B*1502 Patients carrying the HLA-B*1502 allele may be at...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts